Site
Search results (Showing 1 - 10 of 108 results)
-
References | 15 Apr 2010
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.
-
References | 28 Mar 2012
Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.
Johnson KPExpert Rev Neurother. 2012 Apr; 12(4):371-84. PMID: 22449210. Abstract -
References | 26 May 2012
Managing fatigue in patients with multiple sclerosis.
Johnson CMNursing. 2012 Jun; 42(6):26-9. PMID: 22627818. Abstract -
References | 18 Jul 2012
Simvastatin in acute optic neuritis.
Johnson MA, Cadavid DMult Scler. 2012 Jul 16. PMID: 22801929. Abstract -
References | 29 Nov 2013
Aging with a disability and state vocational rehabilitation services.
Brown P, Johnson KWork. 2013 Nov 27. PMID: 24284671. Abstract -
References | 6 Aug 2013
Multiple sclerosis rehabilitation.
Johnson SL, Kraft GHPhys Med Rehabil Clin N Am. 2013 Nov; 24(4):xvii-xviii. Epub 2013 Aug 06. PMID: 24314695. Abstract -
References | 1 Jan 1993
Cognitive Impairments in Multiple SclerosisImplications for Rehabilitation.
DeLuca J, Johnson SKNeuroRehabilitation. 1993; 3(4):9-16. PMID: 24526152. Abstract -
References | 9 May 2014
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Ahmed CM, Johnson HMJ Interferon Cytokine Res. 2014 May 8. PMID: 24811478. Abstract -
References | 12 Jun 2014
Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review.
Johnson B, Nichols SPalliat Support Care. 2014 Jun 11:1-5. PMID: 24916672. Abstract -
References | 21 Nov 2014
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a.
Amor AF, Trochanov A, Johnson JMult Scler Relat Disord. 2014 Nov; 3(6):756-7. Epub 2014 Nov 21. PMID: 25891600. Abstract